Paul Tudor Jones's VKTX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 197,331 shares of Viking Therapeutics, Inc. (VKTX) worth $7.7 M, representing 0.01% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in VKTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 172,124 shares. Largest reduction occurred in Q2 2025, reducing 172,124 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Viking Therapeutics (VKTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Viking Therapeutics (VKTX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +126,542 | Add 178.76% | 197,331 | $39.01 |
| Q1 2026 | +22,180 | Add 45.63% | 70,789 | $32.54 |
| Q4 2025 | +48,609 | New Buy | 48,609 | $35.18 |
| Q2 2025 | -172,124 | Sold Out | 0 | $0.00 |
| Q1 2025 | +172,124 | New Buy | 172,124 | $24.15 |
| Q3 2023 | -41,544 | Sold Out | 0 | $0.00 |
| Q2 2023 | +13,652 | Add 48.95% | 41,544 | $16.21 |
| Q1 2023 | +13,000 | Add 87.30% | 27,892 | $0.02 |
| Q4 2022 | +14,892 | New Buy | 14,892 | $0.01 |
Paul Tudor Jones's Viking Therapeutics Investment FAQs
Paul Tudor Jones first purchased Viking Therapeutics, Inc. (VKTX) in Q4 2022, acquiring 14,892 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Viking Therapeutics, Inc. (VKTX) for 9 quarters since Q4 2022.
Paul Tudor Jones's largest addition to Viking Therapeutics, Inc. (VKTX) was in Q1 2025, adding 172,124 shares worth $4.16 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 197,331 shares of Viking Therapeutics, Inc. (VKTX), valued at approximately $7.7 M.
As of the Q2 2026 filing, Viking Therapeutics, Inc. (VKTX) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Viking Therapeutics, Inc. (VKTX) was 197,331 shares, as reported at the end of Q2 2026.